Qube Research & Technologies (QRT)
NERV icon

Qube Research & Technologies (QRT)’s Minerva Neurosciences NERV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,916
Closed -$36K – 2587
2021
Q2 		$36K Buy
+1,916
New +$41.2K ﹤0.01% 2051

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NERV Position: Q3 2021 in Review

Qube Research & Technologies (QRT) sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 1,916 shares — an estimated $36K sold.

Qube Research & Technologies (QRT) first reported a position in NERV in Q2 2021 and held it in 1 quarter. The position peaked at $36K in Q2 2021. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • Qube Research & Technologies (QRT) reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,916 Minerva Neurosciences shares in Q3 2021, an estimated $36K.
  • Qube Research & Technologies (QRT) first reported a position in Minerva Neurosciences in Q2 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Minerva Neurosciences position peaked at $36K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2021, filed 12 Nov 2021.